Radiation oncology and interventional cardiology firm Implant Sciences has received a $100,000 grant from the National Institutes of Health to be used in the development of an improved high-dose-rate (HDR) brachytherapy system, according to the Wakefield, MA-based company.
The initial portion of the grant will be used to create a prototype treatment catheter for performing cancer procedures and to measure the radiation dose pattern from the company’s HDR brachytherapy system. After completing the dosimetry studies, Implant Sciences could receive an additional $750,000 to develop a portable treatment device and collateral local shielding that will permit HDR treatments to be performed in an ordinary treatment room, Implant Sciences said.
The company is collaborating with the brachytherapy physics team at the Memorial Sloan-Kettering Cancer Center in New York City to develop the treatment.
By AuntMinnie.com staff writersApril 17, 2003
Related Reading
Implant Sciences gets CE Mark for I-125 brachytherapy seeds, August 2, 2001
Copyright © 2003 AuntMinnie.com
